- New Purchases: TGT, GMAB, VIR, TPB,
- Added Positions: XNCR, ESPR, VZ, GLD, ALXN, GDXJ, INTC, NOK, BIF, GOOG, LOW, BOX, REGN, SGMO, KIRK, ET,
- Reduced Positions: BMY, BRK.B, GDX, AMD, ABBV, C, T, SGEN, AMGN, CSCO, MU, XLNX, ALNY, WBA, FGEN, AAPL, APTV, ITCI, INCY, AMRN, AOD, MTNB, ADMS, ARNA,
- Sold Out: SQ, GM, JPM, ADBE, KSS, OVV, BGY,
For the details of DCF Advisers, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/dcf+advisers%2C+llc/current-portfolio/portfolio
These are the top 5 holdings of DCF Advisers, LLC- SPDR GOLD TRUST (GLD) - 70,000 shares, 8.00% of the total portfolio. Shares added by 7.69%
- Intra-Cellular Therapies Inc (ITCI) - 425,500 shares, 7.46% of the total portfolio. Shares reduced by 1.62%
- Alphabet Inc (GOOG) - 6,650 shares, 6.42% of the total portfolio. Shares added by 3.10%
- Micron Technology Inc (MU) - 157,500 shares, 5.54% of the total portfolio. Shares reduced by 3.08%
- Regeneron Pharmaceuticals Inc (REGN) - 12,400 shares, 5.28% of the total portfolio. Shares added by 2.06%
DCF Advisers, LLC initiated holding in Target Corp. The purchase prices were between $92.57 and $125.2, with an estimated average price of $113.71. The stock is now traded at around $136.90. The impact to a portfolio due to this purchase was 0.41%. The holding were 5,000 shares as of .
New Purchase: Genmab A/S (GMAB)DCF Advisers, LLC initiated holding in Genmab A/S. The purchase prices were between $20.05 and $33.89, with an estimated average price of $27.12. The stock is now traded at around $37.02. The impact to a portfolio due to this purchase was 0.29%. The holding were 12,500 shares as of .
New Purchase: Vir Biotechnology Inc (VIR)DCF Advisers, LLC initiated holding in Vir Biotechnology Inc. The purchase prices were between $27.89 and $47.86, with an estimated average price of $33.51. The stock is now traded at around $52.95. The impact to a portfolio due to this purchase was 0.21%. The holding were 7,500 shares as of .
New Purchase: Turning Point Brands Inc (TPB)DCF Advisers, LLC initiated holding in Turning Point Brands Inc. The purchase prices were between $19.68 and $25.65, with an estimated average price of $22.92. The stock is now traded at around $31.04. The impact to a portfolio due to this purchase was 0.17%. The holding were 9,750 shares as of .
Added: Xencor Inc (XNCR)DCF Advisers, LLC added to a holding in Xencor Inc by 126.63%. The purchase prices were between $27.76 and $33.42, with an estimated average price of $30.65. The stock is now traded at around $34.20. The impact to a portfolio due to this purchase was 2.35%. The holding were 190,367 shares as of .
Added: Esperion Therapeutics Inc (ESPR)DCF Advisers, LLC added to a holding in Esperion Therapeutics Inc by 120.45%. The purchase prices were between $30.04 and $51.31, with an estimated average price of $41.62. The stock is now traded at around $33.63. The impact to a portfolio due to this purchase was 0.93%. The holding were 48,500 shares as of .
Added: Verizon Communications Inc (VZ)DCF Advisers, LLC added to a holding in Verizon Communications Inc by 43.75%. The purchase prices were between $52.92 and $58.46, with an estimated average price of $56.2. The stock is now traded at around $59.18. The impact to a portfolio due to this purchase was 0.66%. The holding were 57,500 shares as of .
Added: Alexion Pharmaceuticals Inc (ALXN)DCF Advisers, LLC added to a holding in Alexion Pharmaceuticals Inc by 44.44%. The purchase prices were between $89.77 and $119.9, with an estimated average price of $105.7. The stock is now traded at around $103.31. The impact to a portfolio due to this purchase was 0.31%. The holding were 13,000 shares as of .
Added: VANECK VECTORS ETF (GDXJ)DCF Advisers, LLC added to a holding in VANECK VECTORS ETF by 21.43%. The purchase prices were between $28.1 and $49.58, with an estimated average price of $42.12. The stock is now traded at around $60.71. The impact to a portfolio due to this purchase was 0.25%. The holding were 42,500 shares as of .
Added: Intel Corp (INTC)DCF Advisers, LLC added to a holding in Intel Corp by 50.00%. The purchase prices were between $51.88 and $64.34, with an estimated average price of $59.71. The stock is now traded at around $48.65. The impact to a portfolio due to this purchase was 0.2%. The holding were 15,000 shares as of .
Sold Out: Square Inc (SQ)DCF Advisers, LLC sold out a holding in Square Inc. The sale prices were between $43.72 and $104.94, with an estimated average price of $76.
Sold Out: General Motors Co (GM)DCF Advisers, LLC sold out a holding in General Motors Co. The sale prices were between $18.04 and $30.68, with an estimated average price of $24.29.
Sold Out: JPMorgan Chase & Co (JPM)DCF Advisers, LLC sold out a holding in JPMorgan Chase & Co. The sale prices were between $84.03 and $113.45, with an estimated average price of $94.84.
Sold Out: Adobe Inc (ADBE)DCF Advisers, LLC sold out a holding in Adobe Inc. The sale prices were between $293.61 and $440.55, with an estimated average price of $369.18.
Sold Out: Kohl's Corp (KSS)DCF Advisers, LLC sold out a holding in Kohl's Corp. The sale prices were between $11.51 and $28.83, with an estimated average price of $19.19.
Sold Out: Blackrock Enhanced International Dividend Trust (BGY)DCF Advisers, LLC sold out a holding in Blackrock Enhanced International Dividend Trust. The sale prices were between $4.38 and $5.3, with an estimated average price of $4.94.
Here is the complete portfolio of DCF Advisers, LLC. Also check out:
1. DCF Advisers, LLC's Undervalued Stocks
2. DCF Advisers, LLC's Top Growth Companies, and
3. DCF Advisers, LLC's High Yield stocks
4. Stocks that DCF Advisers, LLC keeps buying